Second-line real-world treatment patterns and outcomes in patients with advanced/metastatic non-small cell lung cancer treated with first line immuno-oncology monotherapy

समान संसाधन

• Ramucirumab with paclitaxel or FOLFIRI as second-line treatment in docetaxel-pre-treated patients with metastatic gastric cancer in real-world setting
  द्वारा: N. S. Besova, और अन्य
  प्रकाशित: (2021-06-01)
• Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma after Discontinuing Pembrolizumab as a Second-Line Treatment: A Retrospective Multicenter Real-World Cohort Study
  द्वारा: Toyohiro Yamada, और अन्य
  प्रकाशित: (2022-09-01)
• Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices
  द्वारा: Vamsidhar Velcheti, और अन्य
  प्रकाशित: (2021-04-01)
• Early Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Breast Cancer Treated with Eribulin After Prior Immuno-Oncology or Antibody–Drug Conjugate Therapy
  द्वारा: Goyal RK, और अन्य
  प्रकाशित: (2023-11-01)
• Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial
  द्वारा: Ulka Vaishampayan, और अन्य
  प्रकाशित: (2019-10-01)